Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Bolni Nagalo

Concepts (213)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Blood Donors
11
2021
32
3.830
 Why?
Hepatitis B
8
2023
23
2.060
 Why?
Oncolytic Virotherapy
3
2022
18
1.640
 Why?
HIV Infections
11
2021
352
1.550
 Why?
Hepatitis B Surface Antigens
4
2018
9
1.480
 Why?
Syphilis
7
2019
27
1.280
 Why?
Liver Neoplasms
6
2025
327
1.260
 Why?
Carcinoma, Hepatocellular
5
2025
196
1.180
 Why?
Hepatitis C
5
2021
80
1.110
 Why?
Blood Transfusion
3
2021
129
1.100
 Why?
Seroepidemiologic Studies
10
2021
50
0.880
 Why?
Burkina Faso
16
2023
16
0.870
 Why?
Vesicular Stomatitis
1
2022
1
0.810
 Why?
Enzyme-Linked Immunosorbent Assay
4
2018
234
0.730
 Why?
Biliary Tract Neoplasms
4
2022
9
0.720
 Why?
HIV Antibodies
1
2018
10
0.630
 Why?
Blood-Borne Pathogens
1
2018
7
0.620
 Why?
HIV-1
4
2018
54
0.570
 Why?
Gabon
4
2019
4
0.500
 Why?
Mass Screening
1
2018
344
0.490
 Why?
Hepatitis B virus
3
2025
26
0.440
 Why?
Rural Population
1
2018
555
0.440
 Why?
Young Adult
11
2021
4106
0.440
 Why?
Humans
37
2025
50509
0.420
 Why?
Skin Neoplasms
3
2024
491
0.420
 Why?
HIV Seroprevalence
2
2014
4
0.410
 Why?
Vesiculovirus
2
2022
6
0.410
 Why?
Bile Duct Neoplasms
2
2022
27
0.390
 Why?
Cholangiocarcinoma
2
2022
25
0.390
 Why?
Adult
17
2025
13583
0.380
 Why?
Adolescent
10
2021
6447
0.370
 Why?
Antibodies, Viral
1
2011
94
0.370
 Why?
Communicable Diseases
1
2011
52
0.360
 Why?
Plasma
1
2011
46
0.360
 Why?
Polymorphism, Single Nucleotide
2
2025
475
0.330
 Why?
Melanoma
2
2024
280
0.320
 Why?
Female
18
2025
27086
0.280
 Why?
Middle Aged
13
2025
12614
0.280
 Why?
Prevalence
6
2018
971
0.280
 Why?
Male
15
2025
25910
0.270
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2022
1000
0.270
 Why?
Cell Line, Tumor
4
2024
1398
0.270
 Why?
Antineoplastic Agents
3
2024
1172
0.260
 Why?
Sensitivity and Specificity
2
2018
861
0.260
 Why?
Hepacivirus
2
2018
105
0.250
 Why?
Hepatitis B, Chronic
1
2025
17
0.240
 Why?
Cell Proliferation
4
2024
985
0.240
 Why?
Extracellular Matrix Proteins
1
2025
68
0.230
 Why?
Molecular Docking Simulation
2
2023
73
0.230
 Why?
Animals
7
2024
13124
0.220
 Why?
Monophenol Monooxygenase
1
2023
5
0.220
 Why?
Incidence
2
2021
1032
0.220
 Why?
Carcinoma, Pancreatic Ductal
1
2024
31
0.220
 Why?
Anti-HIV Agents
2
2014
42
0.220
 Why?
Drug Synergism
2
2021
151
0.210
 Why?
Psoriasis
1
2023
27
0.200
 Why?
Doxorubicin
1
2024
236
0.200
 Why?
Dermatitis
1
2023
35
0.200
 Why?
Vesicular stomatitis Indiana virus
1
2022
2
0.200
 Why?
Antioxidants
2
2023
239
0.200
 Why?
Mice
5
2024
5687
0.200
 Why?
Students, Medical
1
2023
160
0.180
 Why?
Pancreatic Neoplasms
1
2024
206
0.180
 Why?
Treponema pallidum
2
2018
10
0.180
 Why?
Flavonols
1
2020
2
0.180
 Why?
Viral Proteins
1
2022
153
0.180
 Why?
Risk Factors
4
2020
3724
0.180
 Why?
Disease Models, Animal
2
2023
1436
0.180
 Why?
Cymbopogon
1
2020
1
0.170
 Why?
Oils, Volatile
1
2020
12
0.170
 Why?
Immunotherapy
2
2021
235
0.170
 Why?
Protein Kinase Inhibitors
1
2021
204
0.170
 Why?
Sequence Deletion
1
2020
67
0.170
 Why?
Receptors, KIR
1
2019
13
0.170
 Why?
Genotype
4
2025
533
0.160
 Why?
Plasma Membrane Calcium-Transporting ATPases
1
2019
2
0.160
 Why?
Glutathione Transferase
1
2020
172
0.160
 Why?
Polymorphism, Genetic
1
2020
180
0.160
 Why?
Retrospective Studies
6
2022
6263
0.160
 Why?
Gene Frequency
3
2025
97
0.160
 Why?
Virology
1
2018
7
0.160
 Why?
Genetic Predisposition to Disease
4
2025
511
0.160
 Why?
Anti-Inflammatory Agents
1
2020
163
0.150
 Why?
HIV
1
2018
25
0.150
 Why?
Aged
6
2022
9743
0.150
 Why?
Molecular Structure
3
2024
296
0.150
 Why?
Case-Control Studies
4
2025
1156
0.140
 Why?
Immunotherapy, Adoptive
1
2018
163
0.130
 Why?
Blood Pressure
1
2019
531
0.130
 Why?
Odds Ratio
1
2018
551
0.130
 Why?
T-Lymphocytes
1
2018
325
0.130
 Why?
Polymerase Chain Reaction
2
2014
449
0.130
 Why?
Cross-Sectional Studies
2
2018
1609
0.130
 Why?
Cisplatin
3
2022
286
0.120
 Why?
HIV-2
1
2014
1
0.120
 Why?
Hospitals, Military
1
2014
7
0.120
 Why?
Time Factors
2
2018
2934
0.120
 Why?
Antibodies, Monoclonal
1
2018
462
0.120
 Why?
RNA, Viral
2
2014
107
0.110
 Why?
Drug Monitoring
1
2014
79
0.110
 Why?
Syphilis Serodiagnosis
1
2014
4
0.110
 Why?
Peritonitis
1
2014
25
0.110
 Why?
Community-Acquired Infections
1
2014
39
0.110
 Why?
Immunocompromised Host
1
2014
119
0.110
 Why?
Viremia
1
2014
22
0.110
 Why?
Neoplasms
1
2023
1254
0.110
 Why?
Alleles
2
2025
256
0.110
 Why?
Meningitis, Bacterial
1
2013
6
0.100
 Why?
Infectious Disease Transmission, Vertical
1
2012
15
0.100
 Why?
Rubella
1
2012
4
0.100
 Why?
Antiretroviral Therapy, Highly Active
1
2012
32
0.100
 Why?
Toxoplasmosis
1
2012
15
0.100
 Why?
Antibodies, Protozoan
1
2012
12
0.100
 Why?
Bacteria
1
2014
218
0.100
 Why?
Pilot Projects
2
2013
699
0.100
 Why?
Bile Ducts, Intrahepatic
2
2022
13
0.100
 Why?
Real-Time Polymerase Chain Reaction
1
2013
181
0.100
 Why?
Drug Screening Assays, Antitumor
2
2024
131
0.100
 Why?
Apoptosis
3
2024
1097
0.100
 Why?
TOR Serine-Threonine Kinases
2
2023
78
0.090
 Why?
Liver Cirrhosis
2
2025
229
0.090
 Why?
Pregnancy Complications, Infectious
1
2012
75
0.090
 Why?
Structure-Activity Relationship
2
2024
395
0.090
 Why?
Deoxycytidine
2
2021
30
0.090
 Why?
Hospitals, Teaching
1
2011
54
0.090
 Why?
Autophagy
2
2023
170
0.090
 Why?
Tumor Microenvironment
2
2024
222
0.090
 Why?
Xenograft Model Antitumor Assays
2
2021
212
0.090
 Why?
Cohort Studies
2
2025
1452
0.080
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2011
572
0.080
 Why?
Programmed Cell Death 1 Receptor
2
2021
39
0.080
 Why?
Tumor Cells, Cultured
2
2020
457
0.080
 Why?
Prospective Studies
2
2012
2378
0.080
 Why?
Anti-Bacterial Agents
1
2014
743
0.080
 Why?
Ionic Liquids
1
2024
1
0.060
 Why?
Ablation Techniques
1
2024
22
0.060
 Why?
Hydrogels
1
2024
17
0.060
 Why?
Delayed-Action Preparations
1
2024
56
0.060
 Why?
rho-Associated Kinases
1
2024
20
0.060
 Why?
Hedgehog Proteins
1
2024
32
0.060
 Why?
Blood Banks
2
2014
18
0.060
 Why?
Azoles
1
2023
27
0.050
 Why?
Immunomodulation
1
2024
36
0.050
 Why?
Rabbits
1
2024
372
0.050
 Why?
HLA-DRB1 Chains
1
2023
5
0.050
 Why?
Research
1
2023
106
0.050
 Why?
HLA Antigens
1
2023
52
0.050
 Why?
Interleukin-17
1
2023
37
0.050
 Why?
Pyrazoles
1
2023
111
0.050
 Why?
Computer Simulation
1
2023
279
0.050
 Why?
Medical Oncology
1
2023
99
0.050
 Why?
Sirolimus
1
2023
62
0.050
 Why?
Platinum
1
2022
11
0.050
 Why?
Clone Cells
1
2022
70
0.050
 Why?
Proto-Oncogene Proteins c-akt
1
2023
156
0.050
 Why?
Phosphatidylinositol 3-Kinases
1
2023
140
0.050
 Why?
Cyclin-Dependent Kinase 6
1
2021
2
0.050
 Why?
Cyclin-Dependent Kinase 4
1
2021
11
0.050
 Why?
Program Evaluation
1
2023
349
0.050
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2021
11
0.050
 Why?
Pregnancy
3
2014
2451
0.050
 Why?
Enzyme Inhibitors
1
2023
377
0.050
 Why?
Cyclin-Dependent Kinase 2
1
2020
13
0.050
 Why?
Proto-Oncogene Proteins c-kit
1
2020
34
0.040
 Why?
Curriculum
1
2023
397
0.040
 Why?
Cytidine Monophosphate
1
2020
1
0.040
 Why?
Flame Ionization
1
2020
3
0.040
 Why?
Medicine, Traditional
1
2020
19
0.040
 Why?
Mice, Inbred NOD
1
2020
91
0.040
 Why?
Plant Leaves
1
2020
40
0.040
 Why?
Gas Chromatography-Mass Spectrometry
1
2020
68
0.040
 Why?
Mice, SCID
1
2020
178
0.040
 Why?
Aldehydes
1
2020
82
0.040
 Why?
Cytokines
1
2023
606
0.040
 Why?
Genomics
1
2021
279
0.040
 Why?
Lipids
1
2020
152
0.040
 Why?
DNA, Viral
1
2019
136
0.040
 Why?
Sesquiterpenes
1
2020
88
0.040
 Why?
Cell Survival
1
2020
589
0.040
 Why?
Immunohistochemistry
1
2021
957
0.040
 Why?
Genetic Association Studies
1
2019
119
0.040
 Why?
CTLA-4 Antigen
1
2018
23
0.040
 Why?
Inflammation
1
2023
610
0.040
 Why?
Alcohol Drinking
1
2020
227
0.040
 Why?
Rats
1
2024
3292
0.040
 Why?
Neoplasm Recurrence, Local
1
2021
629
0.040
 Why?
Dose-Response Relationship, Drug
1
2020
1372
0.030
 Why?
Signal Transduction
1
2024
1624
0.030
 Why?
Body Mass Index
1
2020
677
0.030
 Why?
Phenotype
1
2019
739
0.030
 Why?
Smoking
1
2020
507
0.030
 Why?
CD4 Lymphocyte Count
1
2014
32
0.030
 Why?
Aged, 80 and over
1
2022
3228
0.030
 Why?
Risk Assessment
1
2019
1270
0.030
 Why?
Opportunistic Infections
1
2014
57
0.030
 Why?
Reagent Kits, Diagnostic
1
2014
17
0.030
 Why?
Genotyping Techniques
1
2014
20
0.030
 Why?
Hepatitis C Antibodies
1
2014
19
0.030
 Why?
Donor Selection
1
2014
18
0.030
 Why?
Drug Resistance, Bacterial
1
2014
72
0.030
 Why?
Drug Therapy, Combination
1
2014
384
0.030
 Why?
Weight Gain
1
2014
237
0.030
 Why?
Microbial Sensitivity Tests
1
2014
269
0.030
 Why?
Pregnancy Complications, Parasitic
1
2012
4
0.030
 Why?
Antibodies, Anti-Idiotypic
1
2012
25
0.030
 Why?
Molecular Diagnostic Techniques
1
2013
33
0.030
 Why?
Water
1
2012
76
0.020
 Why?
Disease Progression
1
2014
829
0.020
 Why?
Comorbidity
1
2014
623
0.020
 Why?
Socioeconomic Factors
1
2012
591
0.020
 Why?
Follow-Up Studies
1
2014
2241
0.020
 Why?
Treatment Outcome
1
2014
5285
0.010
 Why?
Child
1
2012
6910
0.010
 Why?
Nagalo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (213) concept(s)
_
Co-Authors Expand Description
See all (7) people
_
Similar People Expand Description
See all (31) people
_
Same Department Expand Description
Search Department